Samrat Pharmachem reports Q4 FY21 PAT at Rs. 1.55 Cr
News

Samrat Pharmachem reports Q4 FY21 PAT at Rs. 1.55 Cr

The company has posted net profit / (loss) of Rs.5.33 crores for the 12 months period ended March 31, 2021

  • By IPP Bureau | July 02, 2021

Samrat Pharmachem has reported total income of Rs.47.73 crores during the period ended March 31, 2021 as compared to Rs.54.94 crores during the period ended December 31, 2020. The company reported total income of Rs.30.35 crores during the period ended March 31, 2020.

The company has posted net profit of Rs.1.55 crores for the period ended March 31, 2021 as against net profit of Rs.1.53 crores for the period ended December 31, 2020. It posted net profit of Rs.0.3934 crores for the period ended March 31, 2020. 

Samrat Pharmachem has reported total income of Rs.179.48 crores during the 12 months period ended March 31, 2021 as compared to Rs.138.02 crores during the 12 months period ended March 31, 2020.

The company has posted net profit / (loss) of Rs.5.33 crores for the 12 months period ended March 31, 2021 as against net profit / (loss) of Rs.4.23 crores for the 12 months period ended March 31, 2020.

Upcoming E-conference

Other Related stories

Startup

Digitization